The FDA has expanded the approval of Odactra to include treatment of house dust mite-induced allergic rhinitis in pediatric patients aged 5 to 11 years.
The U.S. Food and Drug Administration has expanded its indication of ALK's Odactra, a house dust mite allergen tablet, for the treatment of house dust mite-induced allergic rhinitis, with or without ...
The association between house dust mites (HDMs) and atopic dermatitis (AD) has long been a contested issue in both dermatology and allergy/immunology. As AD continues to burden millions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results